When speaking with your GP, it may be helpful to discuss: Your current BMI and any weight-related health conditions Whether you meet the criteria for existing licensed weight management medications Your reproductive health status, contraception, and any plans for pregnancy Any personal or family history of thyroid disease, pancreatitis, or gallbladder problems Your interest in clinical trials, should you wish to explore participation in retatrutide research Staying informed about emerging treatments is entirely reasonable, but it is important to do so through reliable sources such as the NHS website (nhs.uk), NICE (nice.org.uk), and the MHRA (gov.uk/mhra)
Virili C, Bassotti G, Santaguida MG, Iuorio R, Del Duca SC, Mercuri V, Picarelli A, Gargiulo P, Gargano L, Centanni M
Monitor energy and appetite changes
Rx semaglutide Wegovy (semaglutide) is a GLP-1 injection for weight loss
Medical Conditions: History of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2
Warning signs include decreased urine output, swelling in the legs or feet, and unusual fatigue
